AION Labs Launches First Global Call for Application: Artificial Intelligence for Antibody Design Post date October 19, 2021 ← AION Labs committed to industry best practices business ethics and compliance of IFPMA → A partnership between six leading tech and pharma companies wants to create and adopt new AI technologies that could transform the process of drug discovery and development.
AION Labs
AION Labs